Désirée Mfm van der Heijde (Désirée M van der Heijde, Désirée van der Heijde, D van der Heijde, Desirée van der Heijde)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 213

Top Venues

Annals of the rheumatic diseases

RMD open

The Journal of rheumatology

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Bento Silva, Maria Helena Lourenço, Josef S Smolen, Louise Falzon, Jaime C Branco, Désirée Mfm van der Heijde, Robert B M Landewe, Alexandre Sepriano
Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis-a systematic literature review and meta-analysis. Rheumatology (Oxford, England) (2024)
Mary Lucy Marques, Josef S Smolen, Miranda van Lunteren, Rosalinde Anne Stal, Robert B M Landewe, Marleen van de Sande, Karen Minde Fagerli, Inger Jorid Berg, Maikel van Oosterhout, Sofia Exarchou, Roberta Ramonda, Désirée Mfm van der Heijde, Floris A van Gaalen
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort. Annals of the rheumatic diseases (2024)
Karen Holten, Nina Paulshus Sundlisater, Joseph Sexton, Kaja E Kjørholt, Lena Bugge Nordberg, Ellen Moholt, Till Uhlig, Désirée Mfm van der Heijde, Daniel H Solomon, Espen A Haavardsholm, Siri Lillegraven, Anna-Birgitte Aga, null null
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials. RMD open 10 (3) (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology 6 (8) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Catia Duarte, Ricardo Jorge de Oliveira Ferreira, Paco M J Welsing, Johannes W G Jacobs, Laure Gossec, Pedro M Machado, Désirée Mfm van der Heijde, José António Pereira Da Silva
Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose? RMD open 10 (1) (2024)
Manouk de Hooge, Roos Stal, Alexandre Sepriano, Xenofon Baraliakos, Monique Reijnierse, Jüergen Braun, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis. RMD open 10 (2) (2024)
Ana Bento Silva, Maria Helena Lourenço, Josef S Smolen, Louise Falzon, Jaime C Branco, Désirée Mfm van der Heijde, Robert B M Landewe, Alexandre Sepriano
Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis-a systematic literature review and meta-analysis. Rheumatology (Oxford, England) (2024)
Weng Seng Warren Fong, Ting Hui Woon, Yu Heng Kwan, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen, Uta Kiltz
Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study. RMD open 10 (1) (2024)
Mary Lucy Marques, Josef S Smolen, Miranda van Lunteren, Rosalinde Anne Stal, Robert B M Landewe, Marleen van de Sande, Karen Minde Fagerli, Inger Jorid Berg, Maikel van Oosterhout, Sofia Exarchou, Roberta Ramonda, Désirée Mfm van der Heijde, Floris A van Gaalen
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort. Annals of the rheumatic diseases 83 (5) (2024)
Mary Lucy Marques, Josef S Smolen, Miranda van Lunteren, Rosalinde Anne Stal, Robert B M Landewe, Marleen van de Sande, Karen Minde Fagerli, Inger Jorid Berg, Maikel van Oosterhout, Sofia Exarchou, Roberta Ramonda, Désirée Mfm van der Heijde, Floris A van Gaalen
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort. Annals of the rheumatic diseases (2024)
Mary Lucy Marques, Josef S Smolen, Miranda van Lunteren, Rosalinde Anne Stal, Robert B M Landewe, Marleen van de Sande, Karen Minde Fagerli, Inger Jorid Berg, Maikel van Oosterhout, Sofia Exarchou, Roberta Ramonda, Désirée Mfm van der Heijde, Floris A van Gaalen
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort. Annals of the rheumatic diseases 83 (5) (2024)
Ana Bento Silva, Maria Helena Lourenço, Josef S Smolen, Louise Falzon, Jaime C Branco, Désirée Mfm van der Heijde, Robert B M Landewe, Alexandre Sepriano
Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis-a systematic literature review and meta-analysis. Rheumatology (Oxford, England) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Catia Duarte, Ricardo Jorge de Oliveira Ferreira, Paco M J Welsing, Johannes W G Jacobs, Laure Gossec, Pedro M Machado, Désirée Mfm van der Heijde, José António Pereira Da Silva
Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose? RMD open 10 (1) (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology 6 (8) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Mary Lucy Marques, Josef S Smolen, Désirée Mfm van der Heijde, Monique Reijnierse, Torsten Diekhoff, Kay-Geert A Hermann, Floris A van Gaalen, Manouk de Hooge
Atlas for the CT Syndesmophyte Score (CTSS) in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Mary Lucy Marques, Josef S Smolen, Désirée Mfm van der Heijde, Monique Reijnierse, Torsten Diekhoff, Kay-Geert A Hermann, Floris A van Gaalen, Manouk de Hooge
Atlas for the CT Syndesmophyte Score (CTSS) in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Weng Seng Warren Fong, Ting Hui Woon, Yu Heng Kwan, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen, Uta Kiltz
Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study. RMD open 10 (1) (2024)
Manouk de Hooge, Roos Stal, Alexandre Sepriano, Xenofon Baraliakos, Monique Reijnierse, Jüergen Braun, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis. RMD open 10 (2) (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology (2024)
Manouk de Hooge, Roos Stal, Alexandre Sepriano, Xenofon Baraliakos, Monique Reijnierse, Jüergen Braun, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis. RMD open 10 (2) (2024)
Mary Lucy Marques, Josef S Smolen, Désirée Mfm van der Heijde, Monique Reijnierse, Torsten Diekhoff, Kay-Geert A Hermann, Floris A van Gaalen, Manouk de Hooge
Atlas for the CT Syndesmophyte Score (CTSS) in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Catia Duarte, Ricardo Jorge de Oliveira Ferreira, Paco M J Welsing, Johannes W G Jacobs, Laure Gossec, Pedro M Machado, Désirée Mfm van der Heijde, José António Pereira Da Silva
Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose? RMD open 10 (1) (2024)
Catia Duarte, Ricardo Jorge de Oliveira Ferreira, Paco M J Welsing, Johannes W G Jacobs, Laure Gossec, Pedro M Machado, Désirée Mfm van der Heijde, José António Pereira Da Silva
Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose? RMD open 10 (1) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology 6 (8) (2024)
Clementina López Medina, Filip E Van den Bosch, Désirée Mfm van der Heijde, Maxime Dougados, Anna Moltó
When Usual Care Is Not So Usual: Protocol Violations and Generalizability in a Treat-to-Target Strategy Trial in Patients With Axial Spondyloarthritis. Arthritis care & research (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases (2024)
Mary Lucy Marques, Josef S Smolen, Désirée Mfm van der Heijde, Monique Reijnierse, Torsten Diekhoff, Kay-Geert A Hermann, Floris A van Gaalen, Manouk de Hooge
Atlas for the CT Syndesmophyte Score (CTSS) in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Catia Duarte, Ricardo Jorge de Oliveira Ferreira, Paco M J Welsing, Johannes W G Jacobs, Laure Gossec, Pedro M Machado, Désirée Mfm van der Heijde, José António Pereira Da Silva
Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose? RMD open 10 (1) (2024)
Weng Seng Warren Fong, Ting Hui Woon, Yu Heng Kwan, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen, Uta Kiltz
Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study. RMD open 10 (1) (2024)
Josef S Smolen, Robert B M Landewe, Désirée Mfm van der Heijde, Alexandre Sepriano, Oliver M FitzGerald, Mikkel Østergaard, Joanne Homik, Ori Elkayam, J Carter Throne, Margaret J Larché, Gianfranco Ferraccioli, Marina Backhaus, Gilles Boire, Bernard G Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain G Cantagrel, Cornelia F Allaart, Cheryl C M Barnabe, Clifton O Bingham, Dirkjan van Schaardenburg, Hilde Berner Hammer, Rana Dadashova, Edna Hutchings, Joel Paschke, Walter P Maksymowych
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM. Rheumatology (Oxford, England) (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Xenofon Baraliakos, Atul A Deodhar, Désirée Mfm van der Heijde, Marina Magrey, Walter P Maksymowych, Tetsuya Tomita, Huji Xu, Ute Massow, Carmen Fleurinck, Alicia M Ellis, Thomas Vaux, Julie Shepherd-Smith, Alexander Marten, Lianne S Gensler
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies. Annals of the rheumatic diseases (2023)
Atul A Deodhar, Denis Poddubnyy, Proton Rahman, Joerg Ermann, Tetsuya Tomita, Rebeca Bolce, Soyi Liu Leage, Andris Kronbergs, Caroline Johnson, Joana Araújo, Ann Leung, Désirée Mfm van der Heijde
Long-term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program. The Journal of rheumatology (2023)
Désirée Mfm van der Heijde, Anna Moltó, Josef S Smolen, Jüergen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert Davies Inman, Robert B M Landewe, Helena Marzo-Ortega, Victoria Navarro-Compán, Andri Phoka, Denis Poddubnyy, Mikhail Protopopov, John D Reveille, Martin Rudwaleit, Percival Sampaio-Barros, Alexandre Sepriano, Joachim Sieper, Filip E Van den Bosch, Irene van der Horst-Bruinsma, Pedro M Machado, Xenofon Baraliakos
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature. Annals of the rheumatic diseases (2023)
Robert B M Landewe, Luna Sun, Yun-Fei Chen, Mo Daojun, Désirée Mfm van der Heijde
Robust analyses for radiographic progression in rheumatoid arthritis. RMD open 9 (2) (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Rosalinde Anne Stal, Josef S Smolen, Désirée Mfm van der Heijde, Floris A van Gaalen, Xenofon Baraliakos, Pedro M Machado, Manouk de Hooge, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewe, Alexandre Sepriano
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial. RMD open 9 (3) (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Siri Lillegraven, Nina Paulshus Sundlisater, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Åse Stavland Lexberg, Tor Magne Madland, Hallvard Fremstad, Christian A Høili, Gunnstein Bakland, Cristina Spada, Hilde Haukeland, Inger Myrnes Hansen, Ellen Moholt, Till Uhlig, Daniel H Solomon, Désirée Mfm van der Heijde, Tore K Kvien, Espen A Haavardsholm
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial. Annals of the rheumatic diseases (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Valeriia Melokhina, Nina Paulshus Sundlisater, Joseph Sexton, Ulf Sundin, Anna-Birgitte Aga, Kaja E Kjørholt, Lena Bugge Nordberg, Désirée Mfm van der Heijde, Espen Haavardsholm, Siri Lillegraven
Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the ARCTIC study. Annals of the rheumatic diseases (2023)
Roy M Fleischmann, Désirée Mfm van der Heijde, Vibeke Strand, Tatsuya Atsumi, Iain B McInnes, Tsutomu Takeuchi, Peter C Taylor, Marguerite Bracher, David Brooks, John Davies, Christopher Goode, Anubha Gupta, Sumanta Mukherjee, Ciara O'Shea, Didier Saurigny, Lorrie A Schifano, Celia Shelton, Julia E Smith, Millie Wang, Reena Wang, Sarah Watts, Michael E Weinblatt
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2). Annals of the rheumatic diseases (2023)
Victoria Navarro-Compán, Diego Benavent, Dafne Capelusnik, Désirée Mfm van der Heijde, Robert B M Landewe, Denis Poddubnyy, Astrid van Tubergen, Xenofon Baraliakos, Filip E Van den Bosch, Floris A van Gaalen, Lianne S Gensler, Clementina López Medina, Helena Marzo-Ortega, Anna Moltó, Rodolfo Pérez-Alamino, Martin Rudwaleit, Marleen van de Sande, Alice Heaney, Ulrich Weber, Josef S Smolen
ASAS consensus definition of early axial spondyloarthritis. Annals of the rheumatic diseases (2023)
Josef S Smolen, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B M Landewe, Désirée Mfm van der Heijde
Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Ramiro et al . Annals of the rheumatic diseases (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Kastriot Kastrati, Daniel Aletaha, Gerd-Rüdiger R Burmester, Eva Chwala, Christian Dejaco, Maxime Dougados, Iain B McInnes, Angelo Ravelli, Naveed Sattar, Tanja Alexandra Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée Mfm van der Heijde, Marieke J H Voshaar, Kevin L Winthrop, Josef S Smolen, Andreas Kerschbaumer
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases. RMD open 8 (2) (2022)
Casper Webers, Augusta Ortolan, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert B M Landewe, Josef S Smolen, Désirée Mfm van der Heijde, Elena Nikiphorou
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Ricardo Jorge de Oliveira Ferreira, Paco M J Welsing, Johannes W G Jacobs, Laure Gossec, Mwidimi Ndosi, Pedro M Machado, Désirée Mfm van der Heijde, José António Pereira Da Silva
Correspondence on 'Re-examining remission definitions in rheumatoid arthritis: considering the 28-joint Disease Activity Score, C reactive protein level and patient global assessment' by Felson et al . Annals of the rheumatic diseases (2022)
Désirée Mfm van der Heijde, Atul Deodhar, Walter P Maksymowych, Joachim Sieper, Filip Van den Bosch, Tae Hwan Kim, Kishimoto Mitsumasa, Andrew J K Ostor, Bernard Combe, Yunxia Sui, Yuanyuan Duan, Peter K Wung, In-Ho Song
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension. RMD open 8 (2) (2022)
Daniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, Christian Dejaco, Maxime Dougados, Iain B McInnes, Naveed Sattar, Tanja Alexandra Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée Mfm van der Heijde, Marieke Voshaar, Kevin L Winthrop, Angelo Ravelli, Neil Betteridge, Gerd-Rüdiger R Burmester, Johannes W J Bijlsma, Vivian Bykerk, Roberto Caporali, Ernest H S Choy, Catalin Codreanu, Bernard Combe, Mary K Crow, Maarten P T de Wit, Paul Emery, Roy M Fleischmann, Cem Gabay, Merete Lund Hetland, Kimmie L Hyrich, AnnaMaria Iagnocco, John Dudley Isaacs, Joel M Kremer, Xavier Mariette, Peter A Merkel, Eduardo F Mysler, Peter Nash, Michael T Nurmohamed, Karel Pavelka, Gyula Poor, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the rheumatic diseases (2022)
Rosalinde Anne Stal, Xenofon Baraliakos, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewe, Alexandre Sepriano
Role of vertebral corner inflammation and fat deposition on MRI on syndesmophyte development detected on whole spine low-dose CT scan in radiographic axial spondyloarthritis. RMD open 8 (2) (2022)
Anne Boel, Victoria Navarro-Compán, Désirée Mfm van der Heijde
Test-retest reliability of outcome measures: data from three trials in radiographic and non-radiographic axial spondyloarthritis. RMD open 7 (3) (2022)
Casper Webers, Uta Kiltz, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen
The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter? Rheumatology (Oxford, England) (2022)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Monique Reijnierse, Xenofon Baraliakos, Jüergen Braun, Floris A van Gaalen, Josef S Smolen
Low-dose CT hounsfield units: a reliable methodology for assessing vertebral bone density in radiographic axial spondyloarthritis. RMD open 8 (2) (2022)
Rosalinde Anne Stal, Alexandre Sepriano, Floris Alexander van Gaalen, Xenofon Baraliakos, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewé, Désirée Mfm van der Heijde
Associations between syndesmophytes and facet joint ankylosis in radiographic axial spondyloarthritis patients on low-dose CT over 2 years. Rheumatology (Oxford, England) 61 (12) (2022)
Désirée Mfm van der Heijde, Lianne S Gensler, Walter P Maksymowych, Robert B M Landewe, Martin Rudwaleit, Lars Bauer, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri, Bengt Hoepken, Atul A Deodhar
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. RMD open 8 (1) (2022)
Josef S Smolen, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B M Landewe, Filip E Van den Bosch, Boryana Boteva, Ann Bremander, Philippe Carron, Adrian Ciurea, Floris A van Gaalen, Pál Géher, Lianne Gensler, Josef Hermann, Manouk de Hooge, Marketa Husakova, Uta Kiltz, Clementina López Medina, Pedro M Machado, Helena Marzo-Ortega, Anna Moltó, Victoria Navarro-Compán, Michael John Nissen, Fernando M Pimentel-Santos, Denis Poddubnyy, Fabian Proft, Martin Rudwaleit, Mark Telkman, Sizheng Steven Zhao, Nelly Ziadé, Désirée Mfm van der Heijde
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Annals of the rheumatic diseases (2022)
Augusta Ortolan, Casper Webers, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert B M Landewe, Josef S Smolen, Désirée Mfm van der Heijde, Elena Nikiphorou
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Phillip J Mease, Atul A Deodhar, Désirée Mfm van der Heijde, Frank Behrens, Alan J Kivitz, Jeffrey Neal, Jonghyeon Kim, Shalabh Singhal, Miroslawa Nowak, Subhashis Banerjee
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis. Annals of the rheumatic diseases 81 (6) (2022)
Désirée Mfm van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul A Deodhar, Robert D Inman, Hideto Kameda, Xiaofeng Zeng, Yunxia Sui, Xianwei Bu, Aileen L Pangan, Peter Wung, In-Ho Song
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial. Annals of the rheumatic diseases 81 (11) (2022)
Xenofon Baraliakos, Mikkel Østergaard, Robert Gw Lambert, Iris Eshed, Pedro M Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge, Joachim Sieper, Denis Poddubnyy, Martin Rudwaleit, Désirée Mfm van der Heijde, Robert B M Landewe, Walter P Maksymowych
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group. Annals of the rheumatic diseases (2022)
Monica Hernandez Alava, Allan Wailoo, Georgios Chrysanthou, Filipe Barcelos, Floris A van Gaalen, Helena Santos, Karen Minde Fagerli, Laura Gago, Maria Margarida Cunha, Marleen van de Sande, Maura C Couto, Miguel Bernardes, Roberta Ramonda, Sofia Exarchou, Pedro D Carvalho, Désirée Mfm van der Heijde, Pedro M Machado
Measuring quality of life of patients with axial spondyloarthritis for economic evaluation. RMD open 8 (1) (2022)
Anne Boel, Miranda van Lunteren, Clementina López Medina, Joachim Sieper, Désirée Mfm van der Heijde, Floris A van Gaalen
Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study. RMD open 8 (1) (2022)
Josef S Smolen, Robert B M Landewe, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimmie L Hyrich, Janet E Pope, Savia de Souza, Tanja Alexandra Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd-Rüdiger R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, AnnaMaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Thea P M Vliet Vlieland, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the rheumatic diseases (2022)
Sytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, Désirée Mfm van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Josef S Smolen, Robert B M Landewe
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, Josef S Smolen, Désirée Mfm van der Heijde, Roberto Caporali, Christopher J Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Robert B M Landewe
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Victoria Navarro-Compán, Anne Boel, Annelies Boonen, Phillip J Mease, Maxime Dougados, Uta Kiltz, Robert B M Landewe, Xenofon Baraliakos, Wilson Bautista-Molano, Praveena Chiowchanwisawakit, Hanne Dagfinrud, Lara Fallon, Marco Garrido-Cumbrera, Lianne Gensler, Bassel Kamal ElZorkany, Nigil Haroon, Elenore Judy B Uy, Pedro M Machado, Walter Maksymowych, Anna Moltó, Natasha de Peyrecave, Denis Poddubnyy, Mikhail Protopopov, Josef S Smolen, In-Ho Song, Salima van Weely, Désirée Mfm van der Heijde
Instrument selection for the ASAS core outcome set for axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Clementina López Medina, Sylvie Chevret, Anna Moltó, Joachim Sieper, Tuncay Duruöz, Uta Kiltz, Bassel Elzorkany, Najia Hajjaj-Hassouni, Ruben Burgos-Vargas, José Maldonado-Cocco, Nelly Ziadé, Meghna Gavali, Victoria Navarro-Compan, Shue-Fen Luo, Alessandro Biglia, Kim Tae-Jong, Kishimoto Mitsumasa, Fernando M Pimentel-Santos, Jieruo Gu, Laura Muntean, Floris A van Gaalen, Pál Geher, Marina Magrey, Sebastián E Ibáñez-Vodnizza, Wilson Bautista Molano, Walter P Maksymowych, Pedro M Machado, Robert B M Landewe, Désirée Mfm van der Heijde, Maxime Dougados
Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study. RMD open 7 (3) (2022)
Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, Josef S Smolen, Désirée Mfm van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimmie L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Alexandra Stamm, Johan A F Koekkoek, Robert B M Landewe
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Celia A J Michielsens, Nathan den Broeder, Frank Hj van den Hoogen, Elien A M Mahler, Steven Teerenstra, Désirée Mfm van der Heijde, Lise M Verhoef, Alfons A den Broeder
Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial. Annals of the rheumatic diseases 81 (10) (2022)
Queeny Madari, Alexandre Sepriano, Sofia Ramiro, Anna Moltó, Pascal Claudepierre, Daniel Wendling, Maxime Dougados, Désirée Mfm van der Heijde, Floris A van Gaalen
5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohort. RMD open 6 (1) (2021)
Victoria Navarro-Compán, Alexandre Sepriano, Bassel El-Zorkany, Désirée Mfm van der Heijde
Axial spondyloarthritis. Annals of the rheumatic diseases 80 (12) (2021)
Alexandre Sepriano, Josef S Smolen, Désirée Mfm van der Heijde, Robert B M Landewe
Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference. RMD open 7 (2) (2021)
Phillip J Mease, Robert B M Landewe, Proton Rahman, Hasan Tahir, Atul Singhal, Elke Boettcher, Sandra Navarra, Aimee Readie, Shephard Mpofu, Eumorphia Maria Delicha, Luminita Pricop, Désirée Mfm van der Heijde
Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study. RMD open 7 (2) (2021)
Nadia M T Roodenrijs, Attila Hamar, Melinda Kedves, György Nagy, Jacob M van Laar, Désirée Mfm van der Heijde, Paco M J Welsing
Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. RMD open 7 (1) (2021)
Anna Moltó, Désirée Mfm van der Heijde, Filip E Van den Bosch, Maxime Dougados
Response to: 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'' by Cai and Peng. Annals of the rheumatic diseases (2021)
Kishimoto Mitsumasa, Keisuke Ono, Sho Fukui, Satoshi Kawaai, Gautam A Deshpande, Kazuki Yoshida, Naomi Ichikawa, Yuko Kaneko, Taku Kawasaki, Kazuo Matsui, Mitsuhro Morita, Kurisu Tada, Naoho Takizawa, Naoto Tamura, Atsuo Taniguchi, Yoshinori Taniguchi, Shigeyoshi Tsuji, Masato Okada, Shigeto Kobayashi, Yoshinori Komagata, Clementina López Medina, Anna Moltó, Désirée Mfm van der Heijde, Maxime Dougados, Tetsuya Tomita, Shinya Kaname
Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA study. RMD open 7 (3) (2021)
Bernard G Combe, Alan Kivitz, Yoshiya Tanaka, Désirée Mfm van der Heijde, J Abraham Simon, Herbert S B Baraf, Uma Kumar, Franziska Matzkies, Beatrix Bartok, Lei Ye, Ying Guo, Chantal Tasset, John S Sundy, Angelika Jahreis, Mark C Genovese, Neelufar Mozaffarian, Robert B M Landewe, Sang-Cheol Bae, Edward C Keystone, Peter Nash
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial. Annals of the rheumatic diseases 80 (7) (2021)
Atul A Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, Xenofon Baraliakos, Lianne S Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang, Oluwaseyi Dina, Lara Fallon, Keith S Kanik, Désirée Mfm van der Heijde
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Annals of the rheumatic diseases (2021)
György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C van der Goes, Alison Kent, Margot Bakkers, Polina Pchelnikova, Etienne Blaas, Ladislav Senolt, Zoltán Szekanecz, Ernest H S Choy, Maxime Dougados, Johannes W G Jacobs, Rinie Geenen, Johannes W J Bijlsma, Angela Zink, Daniel Aletaha, Leonard Schoneveld, Piet van Riel, Sophie Dumas, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Larissa Valor-Méndez, Kimmie L Hyrich, Ulf Mueller-Ladner, Raluca Bianca Dumitru, Iain B McInnes, Désirée Mfm van der Heijde, Jacob M van Laar
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Annals of the rheumatic diseases (2021)
Mary Lucy Marques, Sofia Ramiro, Pedro M Machado, Désirée Mfm van der Heijde, Floris A van Gaalen
No relationship between bone mineral density and syndesmophyte formation at the same level in the lumbar spine of patients with radiographic axial Spondyloarthritis. RMD open 6 (3) (2021)
Yoshiya Tanaka, Satoshi Soen, Naoki Ishiguro, Hisashi Yamanaka, Toshiyuki Yoneda, Sakae Tanaka, Takeshi Ohira, Takaya Nitta, Naoki Okubo, Harry Genant, Désirée Mfm van der Heijde, Tsutomu Takeuchi
Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction. RMD open 6 (2) (2021)
Anna Moltó, Clementina López Medina, Filip E Van den Bosch, Annelies Boonen, Casper Webers, Emanuelle Dernis, Floris A van Gaalen, Martin Soubrier, Pascal Claudepierre, Athan Baillet, Mirian Starmans-Kool, Anneke Spoorenberg, Peggy Jacques, Philippe Carron, Rik Joos, Jan Lenaerts, Laure Gossec, Sophie Pouplin, Adeline Ruyssen-Witrand, Laetitia Sparsa, Astrid van Tubergen, Désirée Mfm van der Heijde, Maxime Dougados
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial. Annals of the rheumatic diseases 80 (11) (2021)
Clementina López Medina, Anna Moltó, Joachim Sieper, Tuncay Duruöz, Uta Kiltz, Bassel Elzorkany, Najia Hajjaj-Hassouni, Ruben Burgos-Vargas, José Maldonado-Cocco, Nelly Ziadé, Meghna Gavali, Victoria Navarro-Compan, Shue-Fen Luo, Sara Monti, Kim Tae-Jong, Mitsumasa Kishimoto, F M Pimentel-Santos, Jieruo Gu, Ruxandra Schiotis, Floris A van Gaalen, Pál Geher, Marina Magrey, Sebastián Eduardo Ibáñez Vodnizza, Wilson Bautista Molano, Walter Maksymowych, Pedro M Machado, Robert Landewé, Désirée Mfm van der Heijde, Maxime Dougados
Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD open 7 (1) (2021)
Ulf Sundin, Nina Paulshus Sundlisater, Anna-Birgitte Aga, Joseph Sexton, Lena Bugge Nordberg, Hilde Berner Hammer, Désirée Mfm van der Heijde, Tore K Kvien, Espen A Haavardsholm, Siri Lillegraven, null null
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy. RMD open 7 (1) (2021)
Félicie Costantino, Loreto Carmona, Maarten Boers, Marina Backhaus, Peter V Balint, George A W Bruyn, Robin Christensen, Philip Gerard Conaghan, Ricardo Jorge de Oliveira Ferreira, Juan Luis Garrido-Castro, Francis Guillemin, Hilde Berner Hammer, Désirée Mfm van der Heijde, Annamaria Iagnocco, Marion C Kortekaas, Robert B M Landewe, Peter Mandl, Esperanza Naredo, Wolfgang A Schmidt, Mikkel Østergaard, Caroline B Terwee, Ralf Thiele, Maria-Antonietta D'Agostino
EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs). Annals of the rheumatic diseases 80 (7) (2021)
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, Phillip J Mease, Uta Kiltz, Maxime Dougados, Robert B M Landewe, Désirée Mfm van der Heijde
Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey. The Journal of rheumatology 48 (12) (2021)

Désirée Mfm van der Heijde.css-eqlu8i{font-size:small;padding-left:4px;} (Désirée M van der Heijde, Désirée van der Heijde, D van der Heijde, Desirée van der Heijde)

Publication Activity (10 Years)

Top Topics

Top Venues

Désirée Mfm van der Heijde (Désirée M van der Heijde, Désirée van der Heijde, D van der Heijde, Desirée van der Heijde)